FDA calls for healthcare worker feedback to enhance monitoring of AI-enabled medical devices in real-world settings.
Key Details
- 1FDA opens comment window (Sept 30–Dec 1) for real-world monitoring of AI-equipped devices.
- 2Agency seeks input on detection and mitigation of data/model drift and performance changes.
- 3Most current evaluations rely on static retrospective testing, which FDA says is insufficient.
- 4End-users with experience of deployed AI tools are specifically invited to contribute insights.
- 5Recent breakthroughs: FDA Breakthrough Device status for Aidoc's AI triage solution; new AI approaches to body composition assessment (Mass General Brigham), and mammogram-based CVD risk prediction.
Why It Matters
Robust post-market monitoring and ongoing user feedback are vital as more AI tools are deployed in radiology and medical imaging. These regulatory efforts shape safe, effective, and continually improving AI integration in clinical practice.
Source
AI in Healthcare
Related News
•Radiology Business
Radiology Societies Urge Patient Safety in FDA Generative AI Regulation
RSNA and ACR call for patient safety and ongoing monitoring as the FDA considers regulations for generative AI in radiology.
•Radiology Business
New AI Flags Uncertainty in Breast Cancer Imaging Predictions
University of Pittsburgh researchers developed an AI model that quantifies uncertainty in breast cancer diagnostic predictions to enhance trustworthiness.
•AuntMinnie
LLMs Rarely Recommend Unnecessary Imaging, Except for Thyroid Ultrasound
Large language models seldom over-recommend imaging, but thyroid ultrasound guidance shows substantial discrepancies.